Kao Corporation TSE:4452

Kao : Financial Results (kao results fy2025q3 en)

Published

Source: MarketScreener



Consolidated Financial Results for the Nine Months Ended September 30, 2025 [IFRS]

November 6, 2025

Company name: Kao Corporation Tokyo Stock Exchange in Japan Stock code: 4452 (URL: https://www.kao.com/global/en/investor-relations/library/results/) Representative: Yoshihiro Hasebe, President and CEO

Contact person: Yoshimasa Minegishi, Vice President, Financial Controllers, Global

Telephone: +81-3-3660-7111

Scheduled commencement date for dividend payments: -

Preparation of supplementary material on financial results: Yes

Financial results information meeting: Yes (for institutional investors and analysts)

(Amounts less than one million yen are rounded)

  1. Consolidated financial results for the nine months ended September 30, 2025 (from January 1, 2025 to September 30, 2025)
    1. Consolidated operating results (Percentages indicate year-on-year changes)

      Net sales

      Operating income

      Income before income taxes

      Net income

      Nine months ended

      Millions of yen

      Millions of yen

      Millions of yen

      Millions of yen

      September 30, 2025

      1,232,034

      3.5

      114,867

      13.7

      119,412

      14.8

      84,901

      16.4

      September 30, 2024

      1,190,011

      5.7

      101,055

      99.3

      104,016

      90.6

      72,917

      111.1

      Net income attributable to

      owners of the parent

      Comprehensive income

      Basic earnings per share

      Diluted earnings per share

      Nine months ended

      Millions of yen

      Millions of yen

      Yen

      Yen

      September 30, 2025

      84,719

      19.3

      73,729

      (14.4)

      182.64

      -

      September 30, 2024

      71,027

      118.3

      86,162

      (10.2)

      152.85

      -

    2. Consolidated financial position

      Total assets

      Total equity

      Equity attributable to owners of the parent

      Ratio of equity attributable to owners

      of the parent to total assets

      Equity attributable to owners of the

      parent per share

      As of

      Millions of yen

      Millions of yen

      Millions of yen

      Yen

      September 30, 2025

      1,791,798

      1,057,494

      1,029,263

      57.4

      2,245.81

      December 31, 2024

      1,867,237

      1,098,835

      1,066,776

      57.1

      2,296.69

  2. Dividends

    Annual cash dividends per share

    1st quarter end

    2nd quarter end

    3rd quarter end

    Fiscal year end

    Total

    Yen

    Yen

    Yen

    Yen

    Yen

    Fiscal year ended December 31, 2024

    -

    76.00

    -

    76.00

    152.00

    Fiscal year ending December 31, 2025

    -

    77.00

    -

    Fiscal year ending December 31, 2025 (Forecast)

    77.00

    154.00

    Note: Revisions to the most recently announced forecast of cash dividends: None

  3. Forecast of consolidated operating results for the fiscal year ending December 31, 2025 (from January 1, 2025 to December 31, 2025)

    (Percentages indicate year-on-year changes)

    Net Sales

    Operating income

    Income before income taxes

    Net income attributable to owners of the parent

    Basic earnings

    per share

    Fiscal year ending

    Millions of

    yen

    Millions of

    yen

    Millions of

    yen

    Millions of

    yen

    Yen

    December 31, 2025

    1,690,000

    3.8

    165,000

    12.5

    168,000

    11.2

    121,000

    12.3

    262.31

    Note: Revisions to the most recently announced forecast of consolidated operating results: None

  4. Others

(1) Significant changes in the scope of consolidation during the period: None

Newly included:

-

companies

(Company name)

Excluded:

-

companies

(Company name)

(2) Changes in accounting policies and changes in accounting estimates

1) Changes in accounting policies required by IFRS

None

2) Changes in accounting policies due to reasons other than 1)

None

3) Changes in accounting estimates

None

(3) Number of issued shares (ordinary shares)

  1. Total number of issued shares at the end of the period (including treasury shares)

    As of September 30, 2025

    465,900,000 shares

    As of December 31, 2024

    465,900,000 shares

  2. Number of treasury shares at the end of the period

    As of September 30, 2025

    7,596,989 shares

    As of December 31, 2024

    1,415,333 shares

  3. Average number of shares outstanding during the period

Nine months ended September 30, 2025

463,849,224 shares

Nine months ended September 30, 2024

464,672,121 shares

Review of the Japanese-language originals of the attached condensed consolidated financial statements by certified public accountants or an audit firm: None Explanation regarding the appropriate use of forecast of operating results and other special items

(Caution regarding forward-looking statements, etc.)

Forward-looking statements such as earnings forecasts and other projections contained in this release are based on information available at the time of disclosure and assumptions that management believes to be reasonable, and do not constitute guarantees of future performance. Actual results may differ materially from expectations due to various factors.

Please refer to page 9, "1. Qualitative Information on Financial Results for the Nine Months Ended September 30, 2025, (3) Description of Information on Outlook, Including Forecasts of Consolidated Results" for the suppositions that form the assumptions for earnings forecasts and cautions concerning the use of earnings forecasts.

(Remainder of page intentionally left blank.)

Contents of Attachments

1. Qualitative Information on Financial Results for the Nine Months Ended September 30, 2025 ……

2

(1) Description of Operating Results …………………………………………………………………………………

2

(2) Description of Financial Position …………………………………………………………………………………

9

(3) Description of Information on Outlook, Including Forecasts of Consolidated Results ……………

9

2. Condensed Consolidated Financial Statements and Notes …………………………………………………

10

(1) Condensed Consolidated Statement of Financial Position ………………………………………………

10

(2) Condensed Consolidated Statement of Income ……………………………………………………………

12

(3) Condensed Consolidated Statement of Comprehensive Income ………………………………………

13

(4) Condensed Consolidated Statement of Changes in Equity ………………………………………………

14

(5) Condensed Consolidated Statement of Cash Flows ………………………………………………………

16

(6) Notes to Condensed Consolidated Financial Statements …………………………………………………

17

(7) Note regarding Assumption of Going Concern ………………………………………………………………

19

  1. Qualitative Information on Financial Results for the Nine Months Ended September 30, 2025
    1. Description of Operating Results

      Note: Changes and comparisons are all with the same period a year earlier unless otherwise noted. Like-for-like growth rates below exclude the effect of translation of local currencies into Japanese yen. Growth by volume includes changes due to differences in product mix.

      (Billions of yen, except operating margin and per share amounts)

      Nine months ended September 30

      2025

      2024

      Growth

      Net sales

      1,232.0

      1,190.0

      3.5%

      Like-for-like: 4.1%

      Operating income

      114.9

      101.1

      13.7%

      Operating margin (%)

      9.3

      8.5

      -

      Income before income taxes

      119.4

      104.0

      14.8%

      Net income

      84.9

      72.9

      16.4%

      Net income attributable to owners of the parent

      84.7

      71.0

      19.3%

      Basic earnings per share (Yen)

      182.64

      152.85

      19.5%

      In the global economy, conditions remain uncertain due to international supply chain disruptions and rising procurement costs resulting from the impact of changes in tariff policies, in addition to protracted geopolitical risks in Europe and the Middle East. In Japan, the impact of high prices has persisted and recovery in domestic demand has lacked strength.

      According to retail sales and consumer purchasing survey data, the household and personal care products and cosmetics markets in Japan, which are the Kao Group's key markets, grew during the period from January to September 2025 compared with the same period a year earlier.

      To successfully execute its Mid-term Plan 2027 ("K27") in this business environment, the Kao Group has been improving its earning power while building a foundation for global sales expansion toward profitable growth.

      Net sales increased 3.5% compared with the same period a year earlier to 1,232.0 billion yen. Currency translation accounted for a 0.5% decrease and net sales increased 4.1% on a like-for-like basis (breakdown of the increase: 0.6% increase by volume, 3.5% increase by price). Operating income was

      114.9 billion yen, an increase of 13.8 billion yen, and income before income taxes was 119.4 billion yen, an increase of 15.4 billion yen. Net income was 84.9 billion yen, an increase of 12.0 billion yen.

      To improve capital efficiency and further increase shareholders' returns, the Board of Directors of Kao Corporation (the "Company") resolved at a meeting held on August 6, 2025, to repurchase shares of the Company's stock. As of September 30, 2025, the total number of repurchased shares was 6,232,000 for a total amount of 41.7 billion yen.

      The main exchange rates used for translating the financial statement items (income and expenses) of foreign consolidated subsidiaries and associates were as shown below.

      First quarter

      Jan. - Mar.

      Second quarter

      Apr. - Jun.

      Third quarter

      Jul. - Sep.

      U.S. dollar

      152.65 (148.22)

      144.49 (155.72)

      147.41 (149.44)

      Euro

      160.48 (160.99)

      163.73 (167.68)

      172.30 (164.04)

      Chinese yuan

      20.98 (20.63)

      19.98 (21.51)

      20.59 (20.84)

      Note: Figures in parentheses represent the exchange rates for the same period a year earlier.

      Summary of Segment Information

      A summary of the changes to reportable segments implemented during the three months ended March 31, 2025, is as follows. (Reference: 2. Condensed Consolidated Financial Statements and Notes, (6) Notes to Condensed Consolidated Financial Statements, 1. Segment Information on page 17.)

      1. The "Consumer Products Business," "Hygiene and Living Care Business," and "Health and Beauty Care Business" have been renamed the "Global Consumer Care Business," "Hygiene Living Care Business," and "Health Beauty Care Business," respectively.

      2. The Business Connected Business has been newly established within the Global Consumer Care Business. This business consists of commercial-use hygiene products (excluding Washing Systems, LLC), life care products, and other products.

      3. Washing Systems, LLC has been included in the Chemical Business.

      4. Net sales and operating income for the same period a year earlier have been reclassified and restated to reflect the reorganization of segments in items 1 to 3 above.

        Consolidated Results by Segment

        Nine months ended September 30

        Net sales

        Operating income

        2024

        (Billions of yen)

        2025

        (Billions of yen)

        Growth (%)

        Like-for-like (%)

        2024

        2025

        Change (Billions of yen)

        (Billions of yen)

        Operating margin (%)

        (Billions of yen)

        Operating margin (%)

        Fabric and Home Care Products

        268.4

        278.4

        3.7

        3.6

        47.8

        17.8

        51.6

        18.5

        3.8

        Sanitary Products

        124.6

        119.5

        (4.1)

        (2.8)

        6.3

        5.1

        6.1

        5.1

        (0.2)

        Hygiene Living Care Business

        393.0

        397.9

        1.2

        1.6

        54.2

        13.8

        57.7

        14.5

        3.5

        Health Beauty Care Business

        314.7

        321.8

        2.3

        3.0

        25.6

        8.1

        29.6

        9.2

        3.9

        Cosmetics Business

        173.2

        181.2

        4.6

        4.9

        (7.9)

        (4.6)

        3.0

        1.6

        10.9

        Business Connected Business

        29.2

        28.0

        (4.2)

        (4.2)

        4.7

        16.2

        1.2

        4.1

        (3.6)

        Global Consumer Care Business

        910.1

        928.9

        2.1

        2.5

        76.6

        8.4

        91.4

        9.8

        14.8

        Chemical Business

        313.0

        336.9

        7.6

        8.5

        25.9

        8.3

        22.9

        6.8

        (3.0)

        Total

        1,223.1

        1,265.8

        3.5

        4.0

        102.5

        -

        114.3

        -

        11.7

        Elimination and Reconciliation

        (33.1)

        (33.8)

        -

        -

        (1.5)

        -

        0.6

        -

        2.1

        Consolidated

        1,190.0

        1,232.0

        3.5

        4.1

        101.1

        8.5

        114.9

        9.3

        13.8

        Consolidated Net Sales Composition

        (Billions of yen)

        Nine months ended September 30

        Japan

        Asia

        Americas

        Europe

        Consolidated

        Fabric and Home Care Products

        2024

        2025

        232.8

        246.7

        32.9

        29.5

        2.8

        2.3

        -

        -

        268.4

        278.4

        Growth (%)

        6.0

        (10.3)

        (17.6)

        -

        3.7

        Like-for-like (%)

        6.0

        (11.6)

        (13.2)

        -

        3.6

        Sanitary Products

        2024

        2025

        55.3

        53.3

        69.3

        66.2

        -

        -

        -

        -

        124.6

        119.5

        Growth (%)

        (3.5)

        (4.5)

        -

        -

        (4.1)

        Like-for-like (%)

        (3.5)

        (2.2)

        -

        -

        (2.8)

        Hygiene Living Care Business

        2024

        2025

        288.1

        300.0

        102.2

        95.7

        2.8

        2.3

        -

        -

        393.0

        397.9

        Growth (%)

        4.1

        (6.4)

        (17.6)

        -

        1.2

        Like-for-like (%)

        4.1

        (5.2)

        (13.2)

        -

        1.6

        Health Beauty Care Business

        2024

        2025

        155.9

        166.9

        27.1

        26.8

        84.9

        81.7

        46.8

        46.4

        314.7

        321.8

        Growth (%)

        7.1

        (1.1)

        (3.8)

        (0.8)

        2.3

        Like-for-like (%)

        7.1

        0.2

        (1.2)

        (1.7)

        3.0

        Cosmetics Business

        2024

        2025

        116.2

        123.2

        31.9

        32.8

        5.6

        5.3

        19.4

        19.9

        173.2

        181.2

        Growth (%)

        6.0

        2.8

        (5.4)

        2.5

        4.6

        Like-for-like (%)

        6.0

        4.4

        (3.5)

        1.5

        4.9

        Business Connected Business

        2024

        2025

        29.0

        27.7

        0.1

        0.3

        -

        -

        -

        -

        29.2

        28.0

        Growth (%)

        (4.6)

        89.7

        -

        -

        (4.2)

        Like-for-like (%)

        (4.6)

        92.8

        -

        -

        (4.2)

        Global Consumer Care Business

        2024

        2025

        589.2

        617.8

        161.4

        155.6

        93.2

        89.2

        66.2

        66.4

        910.1

        928.9

        Growth (%)

        4.8

        (3.6)

        (4.3)

        0.2

        2.1

        Like-for-like (%)

        4.8

        (2.3)

        (1.7)

        (0.7)

        2.5

        Chemical Business

        2024

        2025

        100.6

        107.0

        77.1

        89.6

        63.0

        65.1

        72.3

        75.2

        313.0

        336.9

        Growth (%)

        6.4

        16.2

        3.3

        4.1

        7.6

        Like-for-like (%)

        6.4

        16.3

        8.1

        3.4

        8.5

        Elimination of intersegment

        2024

        2025

        (27.8)

        (29.5)

        (2.7)

        (2.3)

        (0.1)

        (0.1)

        (2.5)

        (1.9)

        (33.1)

        (33.8)

        Consolidated

        2024

        2025

        662.0

        695.3

        235.8

        242.9

        156.1

        154.1

        136.1

        139.7

        1,190.0

        1,232.0

        Growth (%)

        5.0

        3.0

        (1.3)

        2.6

        3.5

        Like-for-like (%)

        5.0

        3.9

        2.2

        1.8

        4.1

        Notes:

        1. Figures for the Global Consumer Care Business present sales to external customers and figures for the Chemical Business include sales to the Global Consumer Care Business in addition to external customers. Sales by geographic region are classified based on the location of the sales recognized.

        2. The percentage of sales outside Japan to total net sales was 43.6% compared with 44.4% in the same period a year earlier. Starting from the three months ended March 31, 2025, this percentage is disclosed based on the location where the sales were recognized. Figures for the same period a year earlier were recalculated using the same method.

      Analysis of Change in Net Sales Compared with the Same Period a Year Earlier

      Change (%)

      Currency Translation (%)

      Like-for-Like

      (%)

      By Volume (%)

      By Price (%)

      Fabric and Home Care Products

      3.7

      0.1

      3.6

      1.6

      2.0

      Sanitary Products

      (4.1)

      (1.3)

      (2.8)

      (1.5)

      (1.2)

      Hygiene Living Care Business

      1.2

      (0.3)

      1.6

      0.6

      0.9

      Health Beauty Care Business

      2.3

      (0.7)

      3.0

      2.7

      0.2

      Cosmetics Business

      4.6

      (0.3)

      4.9

      4.0

      0.9

      Business Connected Business

      (4.2)

      (0.0)

      (4.2)

      (5.3)

      1.2

      Global Consumer Care Business

      2.1

      (0.4)

      2.5

      1.8

      0.7

      Chemical Business

      7.6

      (0.8)

      8.5

      (2.7)

      11.2

      Total

      3.5

      (0.5)

      4.1

      0.6

      3.5

      Note: Chemical Business sales include intersegment transactions.

      Global Consumer Care Business

      Sales increased 2.1% compared with the same period a year earlier to 928.9 billion yen. Currency translation accounted for a 0.4% decrease and sales increased 2.5% on a like-for-like basis (breakdown of the increase: 1.8% increase by volume, 0.7% increase by price).

      Globally, amid an ongoing consumer orientation toward low prices, demand for products that offer practicality and high added value was firm. In Japan, although widespread wage increases and inbound demand supported the economy, consumer behavior tended to remain cautious due to the impact of rising prices. Under these circumstances, the Kao Group continued to improve its earning power while working to build a foundation for global sales expansion toward profitable growth by offering high-value-added products and increasing selling prices to reflect that added value, among other measures.

      In Japan, sales increased 4.8% to 617.8 billion yen.

      In Asia, sales decreased 3.6% to 155.6 billion yen. On a like-for-like basis, sales decreased 2.3%.

      In the Americas, sales decreased 4.3% to 89.2 billion yen. On a like-for-like basis, sales decreased 1.7%. In Europe, sales increased 0.2% to 66.4 billion yen. On a like-for-like basis, sales decreased 0.7%.

      Operating income increased 14.8 billion yen compared with the same period a year earlier to 91.4 billion yen, even with the impact of an increase in raw material prices, due to the contribution of increased sales volume and improved earning power.

      Note: The Kao Group's Global Consumer Care Business consists of the Hygiene Living Care Business, the Health Beauty Care Business, the Cosmetics Business, and the Business Connected Business.

      Hygiene Living Care Business

      Sales increased 1.2% compared with the same period a year earlier to 397.9 billion yen. Currency translation accounted for a 0.3% decrease and sales increased 1.6% on a like-for-like basis (breakdown of the increase: 0.6% increase by volume, 0.9% increase by price). However, if the impact of the transfer of the pet care business conducted in June 2024 is also excluded, sales increased 2.2% on a like-for-like basis.

      Sales of fabric and home care products increased 3.7% to 278.4 billion yen. Currency translation accounted for a 0.1% increase and sales increased 3.6% on a like-for-like basis (breakdown of the increase: 1.6% increase by volume, 2.0% increase by price).

      Sales of fabric care products increased. In Japan, improved products in the Attack Antibacterial EX series of laundry detergents, among other products, contributed to increased sales and market share expansion, due in part to the effect of price increases along with their enhanced value.

      Sales of home care products increased due to strong performance by improved dishwashing detergents and other products in Japan.

      Operating income for fabric and home care products increased 3.8 billion yen to 51.6 billion yen.

      Sales of sanitary products decreased 4.1% to 119.5 billion yen. Currency translation accounted for a 1.3% decrease and sales decreased 2.8% on a like-for-like basis (breakdown of the decrease: 1.5% decrease by volume, 1.2% decrease by price). However, if the impact of the transfer of the pet care business conducted in June 2024 is also excluded, sales decreased 1.0% on a like-for-like basis.

      Sales of Laurier sanitary napkins increased. In China, sales were strong due to the continued success of loyalty marketing. Sales of Merries baby diapers increased in Japan but decreased in Asia due to aggressive competition and other factors.

      Operating income for sanitary products was 6.1 billion yen, a decrease of 0.2 billion yen. However, excluding the impact of the transfer of the pet care business conducted in June 2024, operating income increased 4.0 billion yen.

      Operating income for the Hygiene Living Care Business increased 3.5 billion yen compared with the same period a year earlier to 57.7 billion yen. However, excluding the impact of the transfer of the pet care business conducted in June 2024, operating income increased 7.8 billion yen.

      Health Beauty Care Business

      Sales increased 2.3% compared with the same period a year earlier to 321.8 billion yen. Currency translation accounted for a 0.7% decrease and sales increased 3.0% on a like-for-like basis (breakdown of the increase: 2.7% increase by volume, 0.2% increase by price).

      Sales of skin care products increased. Sales increased in Japan due to the growth of UV care products and seasonal sheet-type products but decreased in the Americas due to the impact of competition on the JERGENS skin care brand, among other factors.

      Sales of hair care products increased substantially. In Japan, in addition to high-priced hair care brands launched in 2024, new product MEMEME sold strongly. Among products for hair salons in the Americas and Europe, ORIBE for high-end hair salons performed strongly but sales of GOLDWELL decreased due to the impact of factors including worsening business sentiment in the United States and Europe.

      Sales of personal health products increased. Sales of PureOra Carbonic Acid Toothpaste remained strong in Japan and sales of improved MegRhythm thermo products grew in Japan and China.

      Operating income increased 3.9 billion yen compared with the same period a year earlier to 29.6 billion yen. However, excluding the impact of structural reform expenses at subsidiaries in the Americas and Europe in the same period a year earlier, operating income increased 0.2 billion yen.

      Cosmetics Business

      Sales increased 4.6% compared with the same period a year earlier to 181.2 billion yen. Currency translation accounted for a 0.3% decrease and sales increased 4.9% on a like-for-like basis (breakdown of the increase: 4.0% increase by volume, 0.9% increase by price).

      Sales in Japan increased. Continued strong sales of the Kao Group's six focus brands, including the Curél derma care brand, the KANEBO prestige skincare and makeup brand, the SOFINA iP skin care brand, and the SENSAI luxury brand, which captured inbound demand, contributed to the ongoing increase in sales. Sales in Asia also increased. In China, sales increased substantially due to strong performance by freeplus, which is hypoallergenic and contains Japanese and Chinese botanical extracts, in addition to the absence of the restrictions on shipments implemented by the Kao Group in the same period a year earlier to optimize distribution inventory. In Thailand, where the Kao Group is focusing its efforts, the progress of KANEBO and the KATE makeup brand exceeded the plan. In Europe, SENSAI and MOLTON BROWN performed well and the Kao Group stepped up its rollout of Curél.

      Operating income was 3.0 billion yen, an increase of 10.9 billion yen from the same period a year earlier due to the substantial contribution to improved profits from concentrated investment in the six focus brands and business streamlining, among other factors.

      Business Connected Business

      Sales decreased 4.2% compared with the same period a year earlier to 28.0 billion yen. Currency translation accounted for a 0.0% decrease and sales decreased 4.2% on a like-for-like basis (breakdown of the decrease: 5.3% decrease by volume, 1.2% increase by price). However, if the impact of the transfer of the beverage business conducted in August 2024 is also excluded, sales increased 1.6% on a like-for-like basis.

      Sales of commercial-use hygiene products increased. Although products for the medical sector were affected by price competition, demand continued to rise for kitchen cleaning agents and guest room amenities in the food service, lodging, and leisure sectors due to firm market conditions.

      Operating income decreased 3.6 billion yen compared with the same period a year earlier to 1.2 billion yen. However, excluding the impact of the transfer of the beverage business conducted in August 2024, operating income increased 2.7 billion yen.

      Chemical Business

      Sales increased 7.6% compared with the same period a year earlier to 336.9 billion yen. Currency translation accounted for a 0.8% decrease and sales increased 8.5% on a like-for-like basis (breakdown of the increase: 2.7% decrease by volume, 11.2% increase by price).

      In oleo chemicals, although differences in demand emerged in each region, sales increased due to the substantial contribution from selling price adjustments implemented in response to rising prices for fat and oil raw materials.

      In performance chemicals, despite a slump in the automobile-related sector and other target markets, sales were on par with the same period a year earlier due to the contribution from the effects of selling price adjustments.

      In information materials, sales grew as a result of steadily capturing ongoing firm demand in the semiconductor-related, hard disk, and other target sectors.

      Operating income decreased 3.0 billion yen compared with the same period a year earlier to 22.9 billion yen due to factors including a decline in demand in some target sectors and the impact of fluctuating raw material prices.

      (Remainder of page intentionally left blank)

    2. Description of Financial Position Consolidated Financial Position

      (Billions of yen, except per share amounts)

      December 31,

      September 30,

      Incr./(Dcr.)

      2024

      2025

      Total assets

      1,867.2

      1,791.8

      (75.4)

      Total liabilities

      768.4

      734.3

      (34.1)

      Total equity

      1,098.8

      1,057.5

      (41.3)

      Ratio of equity attributable to owners of the parent

      57.1%

      57.4% -

      to total assets

      Equity attributable to owners of the parent per

      2,296.69

      2,245.81

      (50.88)

      share (Yen)

      Bonds and borrowings 131.1

      131.1

      0.0

      Total assets decreased 75.4 billion yen from December 31, 2024, to 1,791.8 billion yen. The principal increase in assets was a 21.1 billion yen increase in inventories. The principal decreases in assets were a

      71.8 billion yen decrease in cash and cash equivalents and a 10.2 billion yen decrease in trade and other receivables.

      Total liabilities decreased 34.1 billion yen from December 31, 2024, to 734.3 billion yen. The principal decrease in liabilities was a 15.3 billion yen decrease in trade and other payables.

      Total equity decreased 41.3 billion yen from December 31, 2024, to 1,057.5 billion yen. The principal increase in equity was net income totaling 84.9 billion yen. The principal decreases in equity were dividends totaling 72.7 billion yen, repurchases of the Company's stock totaling 41.7 billion yen pursuant to a resolution of the Board of Directors at a meeting held on August 6, 2025, and exchange differences on translation of foreign operations totaling 12.2 billion yen.

      The ratio of equity attributable to owners of the parent to total assets was 57.4% compared with 57.1% at December 31, 2024.

    3. Description of Information on Outlook, Including Forecasts of Consolidated Results

    To successfully execute its Mid-term Plan K27, the Kao Group is improving its earning power while building a foundation for global sales expansion toward profitable growth, and progress was as planned for the nine months ended September 30, 2025.

    Despite expectations of an uncertain business environment in the fourth quarter, including the impact of high prices and an intensifying competitive environment outside Japan, there is no change from the forecast of consolidated results announced on August 6, 2025.

    The main exchange rates used in the forecast of consolidated results are one U.S. dollar to 149 yen, one euro to 168 yen, and one Chinese yuan to 20.6 yen.

  2. Condensed Consolidated Financial Statements and Notes
    1. Condensed Consolidated Statement of Financial Position

      Kao Corporation and Consolidated Subsidiaries As of September 30, 2025

      (Millions of yen)

      December 31, 2024

      September 30, 2025

      Change

      Assets

      Current assets

      Cash and cash equivalents

      357,713

      285,880

      (71,833)

      Trade and other receivables

      238,077

      227,840

      (10,237)

      Inventories

      274,628

      295,679

      21,051

      Other financial assets

      10,525

      5,623

      (4,902)

      Income tax receivables

      5,467

      6,192

      725

      Other current assets

      26,053

      26,813

      760

      Subtotal

      912,463

      848,027

      (64,436)

      Non-current assets held for sale

      1,562

      2,232

      670

      Total current assets

      914,025

      850,259

      (63,766)

      Non-current assets

      Property, plant and equipment

      423,251

      426,406

      3,155

      Right-of-use assets

      116,637

      108,272

      (8,365)

      Goodwill

      228,413

      225,188

      (3,225)

      Intangible assets

      81,947

      77,426

      (4,521)

      Investments accounted for using the equity method

      14,526

      14,843

      317

      Other financial assets

      28,132

      28,332

      200

      Deferred tax assets

      49,044

      49,485

      441

      Other non-current assets

      11,262

      11,587

      325

      Total non-current assets

      953,212

      941,539

      (11,673)

      Total assets

      1,867,237

      1,791,798

      (75,439)

      (Millions of yen)

      December 31, 2024

      September 30, 2025

      Change

      Liabilities and equity

      Liabilities

      Current liabilities

      Trade and other payables

      258,035

      242,736

      (15,299)

      Bonds and borrowings

      35,749

      25,857

      (9,892)

      Lease liabilities

      20,146

      20,287

      141

      Other financial liabilities

      7,280

      4,249

      (3,031)

      Income tax payables

      20,984

      25,981

      4,997

      Provisions

      2,773

      1,451

      (1,322)

      Contract liabilities

      43,878

      44,005

      127

      Other current liabilities

      120,755

      112,470

      (8,285)

      Total current liabilities

      509,600

      477,036

      (32,564)

      Non-current liabilities

      Bonds and borrowings

      95,310

      105,225

      9,915

      Lease liabilities

      94,123

      86,304

      (7,819)

      Other financial liabilities

      6,370

      6,647

      277

      Retirement benefit liabilities

      39,460

      37,064

      (2,396)

      Provisions

      8,223

      7,503

      (720)

      Deferred tax liabilities

      9,754

      9,003

      (751)

      Other non-current liabilities

      5,562

      5,522

      (40)

      Total non-current liabilities

      258,802

      257,268

      (1,534)

      Total liabilities

      768,402

      734,304

      (34,098)

      Equity

      Share capital

      85,424

      85,424

      -

      Capital surplus

      106,256

      106,310

      54

      Treasury shares

      (5,924)

      (47,299)

      (41,375)

      Other components of equity

      132,239

      122,328

      (9,911)

      Retained earnings

      748,781

      762,500

      13,719

      Equity attributable to owners of the parent

      1,066,776

      1,029,263

      (37,513)

      Non-controlling interests

      32,059

      28,231

      (3,828)

      Total equity

      1,098,835

      1,057,494

      (41,341)

      Total liabilities and equity

      1,867,237

      1,791,798

      (75,439)

    2. Condensed Consolidated Statement of Income

      Kao Corporation and Consolidated Subsidiaries Nine months ended September 30, 2025

      (Millions of yen)

      Nine months ended September 30,

      2024

      Nine months ended September 30,

      2025

      Change

      Notes

      Net sales

      1

      1,190,011

      1,232,034

      42,023

      Cost of sales

      (730,725)

      (750,699)

      (19,974)

      Gross profit

      459,286

      481,335

      22,049

      Selling, general and administrative expenses

      2

      (363,737)

      (367,336)

      (3,599)

      Other operating income

      24,040

      13,346

      (10,694)

      Other operating expenses

      (18,534)

      (12,478)

      6,056

      Operating income

      1

      101,055

      114,867

      13,812

      Financial income

      3,747

      4,369

      622

      Financial expenses

      (3,543)

      (2,631)

      912

      Share of profit in investments accounted for using the equity

      method

      2,757

      2,807

      50

      Income before income taxes

      104,016

      119,412

      15,396

      Income taxes

      (31,099)

      (34,511)

      (3,412)

      Net income

      72,917

      84,901

      11,984

      Attributable to:

      Owners of the parent

      71,027

      84,719

      13,692

      Non-controlling interests

      1,890

      182

      (1,708)

      Net income

      72,917

      84,901

      11,984

      Earnings per share

      Basic (Yen)

      152.85

      182.64

      Diluted (Yen)

      -

      -

    3. Condensed Consolidated Statement of Comprehensive Income

      Kao Corporation and Consolidated Subsidiaries Nine months ended September 30, 2025

      (Millions of yen)

      Nine months ended September 30,

      2024

      Nine months ended September 30,

      2025

      Change

      Net income

      72,917

      84,901

      11,984

      Other comprehensive income

      Items that will not be reclassified to profit or loss:

      Net gain (loss) on revaluation of

      financial assets measured at fair value through other comprehensive income

      1,050

      503

      (547)

      Remeasurements of defined benefit plans

      -

      (28)

      (28)

      Share of other comprehensive income of investments accounted for using the

      equity method

      318

      855

      537

      Total of items that will not be reclassified to profit or loss

      1,368

      1,330

      (38)

      Items that may be reclassified subsequently to profit or loss:

      Exchange differences on translation of foreign operations

      11,845

      (12,195)

      (24,040)

      Share of other comprehensive income of investments accounted for using the

      equity method

      32

      (307)

      (339)

      Total of items that may be reclassified subsequently to profit or loss

      11,877

      (12,502)

      (24,379)

      Other comprehensive income, net of taxes

      13,245

      (11,172)

      (24,417)

      Comprehensive income

      86,162

      73,729

      (12,433)

      Attributable to:

      Owners of the parent

      82,867

      74,923

      (7,944)

      Non-controlling interests

      3,295

      (1,194)

      (4,489)

      Comprehensive income

      86,162

      73,729

      (12,433)

    4. Condensed Consolidated Statement of Changes in Equity

      Kao Corporation and Consolidated Subsidiaries

      Nine months ended September 30, 2024 (Millions of yen)

      Equity attributable to owners of the parent

      Other components of equity

      Share capital

      Capital surplus

      Treasury shares

      Exchange differences on translation of

      foreign operations

      Net gain (loss) on derivatives designated as cash flow

      hedges

      Net gain (loss) on revaluation of financial

      assets measured at

      fair value

      through other com-

      prehensive

      income

      January 1, 2024

      85,424

      105,780

      (3,267)

      77,448

      10

      6,461

      Net income

      -

      -

      -

      -

      -

      -

      Other comprehensive income

      -

      -

      -

      10,475

      (4)

      1,369

      Comprehensive income

      -

      -

      -

      10,475

      (4)

      1,369

      Disposal of treasury shares

      -

      (182)

      189

      -

      -

      -

      Purchase of treasury shares

      -

      -

      (2,838)

      -

      -

      -

      Share-based payment transactions

      -

      490

      -

      -

      -

      -

      Dividends

      -

      -

      -

      -

      -

      -

      Changes in the

      ownership interest in subsidiaries

      -

      5

      -

      -

      -

      -

      Transfer from other

      components of equity to retained earnings

      -

      -

      -

      -

      -

      (217)

      Total transactions with the owners

      -

      313

      (2,649)

      -

      -

      (217)

      September 30, 2024

      85,424

      106,093

      (5,916)

      87,923

      6

      7,613

      Equity attributable to owners of the parent

      Other components of equity

      Non-controlling interests

      Remeasurements of defined benefit

      plans

      Retained earnings

      Total equity

      Total

      Total

      January 1, 2024

      -

      83,919

      711,802

      983,658

      28,385

      1,012,043

      Net income

      -

      -

      71,027

      71,027

      1,890

      72,917

      Other comprehensive income

      -

      11,840

      -

      11,840

      1,405

      13,245

      Comprehensive income

      -

      11,840

      71,027

      82,867

      3,295

      86,162

      Disposal of treasury shares

      -

      -

      (7)

      0

      -

      0

      Purchase of treasury shares

      -

      -

      -

      (2,838)

      -

      (2,838)

      Share-based payment transactions

      -

      -

      -

      490

      -

      490

      Dividends

      -

      -

      (70,169)

      (70,169)

      (1,001)

      (71,170)

      Changes in the ownership interest in subsidiaries

      -

      -

      -

      5

      (16)

      (11)

      Transfer from other

      components of equity to retained earnings

      -

      (217)

      217

      -

      -

      -

      Total transactions with the owners

      -

      (217)

      (69,959)

      (72,512)

      (1,017)

      (73,529)

      September 30, 2024

      -

      95,542

      712,870

      994,013

      30,663

      1,024,676

      Nine months ended September 30, 2025 (Millions of yen)

      Equity attributable to owners of the parent

      Other components of equity

      Share capital

      Capital surplus

      Treasury shares

      Exchange differences on translation of

      foreign operations

      Net gain (loss) on derivatives designated as cash flow

      hedges

      Net gain (loss) on revaluation of financial

      assets measured at

      fair value

      through other com-

      prehensive

      income

      January 1, 2025

      85,424

      106,256

      (5,924)

      124,321

      6

      7,912

      Net income

      -

      -

      -

      -

      -

      -

      Other comprehensive income

      -

      -

      -

      (11,129)

      2

      1,359

      Comprehensive income

      -

      -

      -

      (11,129)

      2

      1,359

      Disposal of treasury shares

      -

      (320)

      363

      -

      -

      -

      Purchase of treasury shares

      -

      (0)

      (41,738)

      -

      -

      -

      Share-based payment transactions

      -

      496

      -

      -

      -

      -

      Dividends

      -

      -

      -

      -

      -

      -

      Changes in the ownership interest in subsidiaries

      -

      (122)

      -

      -

      -

      -

      Transfer from other

      components of equity to retained earnings

      -

      -

      -

      -

      -

      (143)

      Total transactions with the owners

      -

      54

      (41,375)

      -

      -

      (143)

      September 30, 2025

      85,424

      106,310

      (47,299)

      113,192

      8

      9,128

      Equity attributable to owners of the parent

      Other components of equity

      Non-controlling interests

      Remeasurements of defined benefit

      plans

      Retained earnings

      Total equity

      Total

      Total

      January 1, 2025

      -

      132,239

      748,781

      1,066,776

      32,059

      1,098,835

      Net income

      -

      -

      84,719

      84,719

      182

      84,901

      Other comprehensive income

      (28)

      (9,796)

      -

      (9,796)

      (1,376)

      (11,172)

      Comprehensive income

      (28)

      (9,796)

      84,719

      74,923

      (1,194)

      73,729

      Disposal of treasury shares

      -

      -

      (42)

      1

      -

      1

      Purchase of treasury shares

      -

      -

      -

      (41,738)

      -

      (41,738)

      Share-based payment transactions

      -

      -

      -

      496

      -

      496

      Dividends

      -

      -

      (71,073)

      (71,073)

      (1,663)

      (72,736)

      Changes in the

      ownership interest in subsidiaries

      -

      -

      -

      (122)

      (971)

      (1,093)

      Transfer from other

      components of equity to retained earnings

      28

      (115)

      115

      -

      -

      -

      Total transactions with the owners

      28

      (115)

      (71,000)

      (112,436)

      (2,634)

      (115,070)

      September 30, 2025

      -

      122,328

      762,500

      1,029,263

      28,231

      1,057,494

    5. Condensed Consolidated Statement of Cash Flows

      Kao Corporation and Consolidated Subsidiaries Nine months ended September 30, 2025

      (Millions of yen)

      Nine months ended September 30,

      2024

      Nine months ended September 30,

      2025

      Cash flows from operating activities

      Income before income taxes

      104,016

      119,412

      Depreciation and amortization

      66,427

      63,997

      Gain on transfer of business

      (10,590)

      -

      Interest and dividend income

      (3,518)

      (2,633)

      Interest expense

      2,020

      1,820

      Share of profit in investments accounted for using the equity method

      (2,757)

      (2,807)

      (Gains) losses on sale and disposal of property, plant and equipment, and intangible assets

      1,899

      2,213

      (Increase) decrease in trade and other receivables

      19,654

      9,559

      (Increase) decrease in inventories

      (3,103)

      (22,315)

      Increase (decrease) in trade and other payables

      (2,563)

      (12,287)

      Increase (decrease) in retirement benefit liabilities

      (2,318)

      (2,831)

      Increase (decrease) in provisions

      (10,640)

      (2,024)

      Other

      (5,410)

      (11,608)

      Subtotal

      153,117

      140,496

      Interest received

      3,370

      2,512

      Dividends received

      2,270

      3,377

      Interest paid

      (1,708)

      (2,000)

      Income taxes paid

      (25,143)

      (31,126)

      Net cash flows from operating activities

      131,906

      113,259

      Cash flows from investing activities

      Payments into time deposits

      (9,319)

      (7,272)

      Proceeds from withdrawal of time deposits

      7,980

      11,541

      Purchase of property, plant and equipment

      (41,799)

      (50,329)

      Proceeds from sale of property, plant and equipment

      5,086

      87

      Purchase of intangible assets

      (6,454)

      (6,389)

      Proceeds from transfer of business

      11,783

      -

      Other

      2,328

      269

      Net cash flows from investing activities

      (30,395)

      (52,093)

      Cash flows from financing activities

      Increase (decrease) in short-term borrowings

      (13,404)

      90

      Proceeds from long-term borrowings

      10,000

      10,000

      Repayments of long-term borrowings

      (7)

      (10,014)

      Proceeds from issuance of bonds

      -

      24,939

      Redemption of bonds

      (12)

      (24,951)

      Repayments of lease liabilities

      (16,143)

      (16,658)

      Purchase of treasury shares

      (2,838)

      (41,738)

      Dividends paid to owners of the parent

      (69,625)

      (70,625)

      Dividends paid to non-controlling interests

      (1,021)

      (1,667)

      Other

      70

      (940)

      Net cash flows from financing activities

      (92,980)

      (131,564)

      Net increase (decrease) in cash and cash equivalents

      8,531

      (70,398)

      Cash and cash equivalents at the beginning of the period

      291,663

      357,713

      Effect of exchange rate changes on cash and cash equivalents

      4,268

      (1,435)

      Cash and cash equivalents at the end of the period

      304,462

      285,880

    6. Notes to Condensed Consolidated Financial Statements
      1. Segment Information

        1. Summary of Reportable Segments

          The Kao Group's reportable segments are the components of the Kao Group for which discrete financial information is available and are regularly reviewed by the Board of Directors in deciding how to allocate resources and in assessing their performance. Net sales and operating income are the key measures used by the Board of Directors to evaluate the performance of each segment.

          The Kao Group is organized on the basis of five businesses: the four business areas that constitute the Global Consumer Care Business (the Hygiene Living Care Business, the Health Beauty Care Business, the Cosmetics Business, and the Business Connected Business) and the Chemical Business. In each business, the Kao Group plans comprehensive business strategies and carries out business activities on a global basis.

          Accordingly, the Kao Group has five reportable segments: the Hygiene Living Care Business, the Health Beauty Care Business, the Cosmetics Business, the Business Connected Business, and the Chemical Business.

          Due to a change in organization as of January 1, 2025, the Kao Group reclassified its five former

          reportable segments (the Hygiene and Living Care Business, the Health and Beauty Care Business, the Life Care Business, the Cosmetics Business, and the Chemical Business) into the above-noted five reportable segments (the Hygiene Living Care Business, the Health Beauty Care Business, the Cosmetics Business, the Business Connected Business, and the Chemical Business) from the three months ended March 31, 2025. Segment information for the same period a year earlier has been

          restated to reflect the reclassification.

          Major products by reportable segment are as follows:

          Reportable segments

          Major products

          Global Consumer Care Business

          Hygiene Living Care Business

          Fabric care products

          Laundry detergents, fabric treatments

          Home care products

          Kitchen cleaning products, house cleaning products,

          paper cleaning products

          Sanitary products

          Sanitary napkins, baby diapers

          Health Beauty Care Business

          Skin care products

          Soaps, facial cleansers, body cleansers, UV care

          products

          Hair care products

          Shampoos, conditioners, hair styling agents, hair

          coloring agents, men's products

          Personal health

          products

          Bath additives, oral care products, thermo products

          Cosmetics

          Business

          Cosmetics

          Counseling cosmetics, self-selection cosmetics

          Business Connected

          Business

          Commercial-use hygiene products,

          life care products

          Commercial-use hygiene products, life care products

          Chemical Business

          Oleo chemicals

          Oleochemicals, fat and oil derivatives, surfactants

          and blending products, fragrances

          Performance chemicals

          Water-reducing admixture for concrete, casting sand binders, plastics additives, process chemicals

          for various industries

          Information materials

          Toners/Toner binders, inkjet ink colorants, ink, fine polishing agents and cleaner for hard disk,

          materials and process chemicals for semiconductor

        2. Sales and Results of Reportable Segments Nine months ended September 30, 2024

          Reportable segments Global Consumer Care Business

          (Millions of yen)

          Hygiene

          Health

          Business

          Chemical

          Reconciliation1 Consolidated

          Living Care Beauty Care Cosmetics Connected Subtotal Business Total

          Business

          Business

          Business

          Business

          Net sales

          Sales to customers 393,012 314,704 173,156 29,183 910,055 279,956 1,190,011 1,190,011

          Intersegment sales and transfers2

          - - - - - 33,050 33,050 (33,050)

          Total net sales 393,012 314,704 173,156 29,183 910,055 313,006 1,223,061 (33,050) 1,190,011

          Operating income (loss)

          54,157 25,612 (7,902) 4,730 76,597 25,922 102,519 (1,464) 101,055

          Financial income 3,747

          Financial expenses (3,543)

          Share of profit in

          investments accounted for using the equity method

          Income before income taxes

          Notes:

          2,757

          104,016

          1. The operating income (loss) reconciliation of (1,464) million yen includes corporate expenses not allocated to reportable segments, as well as elimination of intersegment inventory transactions.

          2. Intersegment sales and transfers are mainly calculated based on market price and manufacturing cost.

            Nine months ended September 30, 2025

            Reportable segments Global Consumer Care Business

            (Millions of yen)

            Hygiene

            Health

            Business

            Chemical

            Reconciliation1 Consolidated

            Living Care Beauty Care Cosmetics Connected Subtotal Business Total

            Business

            Business

            Business

            Business

            Net sales

            Sales to customers 397,901 321,834 181,191 27,962 928,888 303,146 1,232,034 1,232,034

            Intersegment sales

            and transfers2 - - - - - 33,787 33,787 (33,787)

            Total net sales 397,901 321,834 181,191 27,962 928,888 336,933 1,265,821 (33,787) 1,232,034

            Operating income (loss)

            57,697 29,558 2,972 1,157 91,384 22,873 114,257 610 114,867

            Financial income 4,369

            Financial expenses (2,631)

            Share of profit in

            investments accounted for using the equity method

            Income before income taxes

            2,807

            119,412

            Notes:

            1. The operating income (loss) reconciliation of 610 million yen includes corporate expenses not allocated to reportable segments, as well as elimination of intersegment inventory transactions.

            2. Intersegment sales and transfers are mainly calculated based on market price and manufacturing cost.

      2. Selling, General and Administrative Expenses

        Selling, general and administrative expenses consist of the following:

        (Millions of yen)

        Nine months ended

        September 30, 2024

        Nine months ended

        September 30, 2025

        Advertising

        61,840

        64,114

        Sales promotion

        37,330

        40,362

        Employee benefits

        132,306

        132,264

        Depreciation

        12,733

        11,525

        Amortization

        8,424

        8,687

        Research and development

        46,448

        45,900

        Other

        64,656

        64,484

        Total

        363,737

        367,336

    7. Note regarding Assumption of Going Concern

None applicable.